GlassScriptPhysician profile
Harishankar Gopakumar
NPI 1356605703
$38,503.51
in general payments reported to CMS, 2019-2025
14 companies · $37K in 2025
The $37K reported for 2025 was more than what 96% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2022: $1,066 · 2023: $75.00 · 2024: $630 · 2025: $37K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $35K · Food and Beverage: $978 · Travel and Lodging: $909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $35,388.00 |
| Food and Beverage | $978.36 |
| Travel and Lodging | $909.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $35,633.67 | 2022-2025 | General - Therapies |
| Olympus Corporation of The Americas | $1,245.49 | 2022-2025 | Single Use Electrosurgical Knife Kd-655, Disposable Distal Attachment |
| Abbvie INC. | $331.85 | 2022-2025 | |
| Steris Corporation | $242.71 | 2022-2024 | |
| Medtronic, INC. | $201.08 | 2022 | |
| Fujifilm Healthcare Americas Corporation | $160.00 | 2023-2024 | |
| Pentax of America, INC. | $143.90 | 2024 | Pentax Medical, Inspira, C2 Cryoballoon Focal Controller |
| E.R. Squibb & Sons, L.L.C. | $123.34 | 2022 | |
| Abbott Laboratories | $122.50 | 2019 | |
| Genzyme Corporation | $110.29 | 2022 | |
| Phathom Pharmaceuticals, INC. | $90.02 | 2024 | Voquezna |
| Janssen Pharmaceuticals, INC | $40.72 | 2019-2022 | |
| Madrigal Pharmaceuticals | $36.26 | 2025 | Rezdiffra |
| Mallinckrodt Enterprises LLC | $21.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harishankar Gopakumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.